BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30671637)

  • 21. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
    Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
    BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
    Graefen M; Karakiewicz PI; Cagiannos I; Hammerer PG; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Huland H; Scardino PT; Kattan MW
    Urol Oncol; 2002; 7(4):141-6. PubMed ID: 12474529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decision-making tools in prostate cancer: from risk grouping to nomograms.
    Fontanella P; Benecchi L; Grasso A; Patel V; Albala D; Abbou C; Porpiglia F; Sandri M; Rocco B; Bianchi G
    Minerva Urol Nefrol; 2017 Dec; 69(6):556-566. PubMed ID: 28376608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
    JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
    McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
    Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring testosterone and testosterone replacement therapy in men receiving androgen deprivation therapy for prostate cancer: A survey of UK uro-oncologists' opinions and practice.
    Payne H; McMenemin R; Bahl A; Greene D; Staffurth J
    Int J Clin Pract; 2019 Sep; 73(9):1-6. PubMed ID: 30414348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy choices of German urologists and radio-oncologists if personally diagnosed with localized prostate cancer].
    Gillitzer R; Hampel C; Thomas C; Schmidt F; Melchior SW; Pahernik S; Schmidberger H; Thüroff JW
    Urologe A; 2009 Apr; 48(4):399-407. PubMed ID: 19352607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity.
    Campbell JM; Raymond E; O'Callaghan ME; Vincent AD; Beckmann KR; Roder D; Evans S; McNeil J; Millar J; Zalcberg J; Borg M; Moretti KL
    Clin Genitourin Cancer; 2017 Oct; 15(5):e827-e834. PubMed ID: 28666689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physician Perception of Grade Group 1 Prostate Cancer.
    Saoud R; Woranisarakul V; Paner GP; Ramotar M; Berlin A; Cooperberg M; Eggener SE
    Eur Urol Focus; 2023 Nov; 9(6):966-973. PubMed ID: 37117112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.
    Wang SY; Cowan JE; Cary KC; Chan JM; Carroll PR; Cooperberg MR
    BJU Int; 2014 Dec; 114(6b):E18-E24. PubMed ID: 24712895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of localized prostate cancer and use of nomograms among urologists in the West Africa sub-region.
    Kyei MY; Adusei B; Klufio GO; Mensah JE; Gepi-Attee S; Asante E
    Pan Afr Med J; 2020; 36():251. PubMed ID: 33014247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?
    Descazeaud A; Rubin MA; Allory Y; Burchardt M; Salomon L; Chopin D; Abbou C; de la Taille A
    Eur Urol; 2005 Dec; 48(6):911-5. PubMed ID: 16140457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty.
    Kim SP; Tilburt JC; Karnes RJ; Ziegenfuss JY; Han LC; Shah ND; Frank I; Smaldone MC; Gross CP; Yu JB; Trinh QD; Sun M; O'Malley RL; Nguyen PL
    Urology; 2013 Oct; 82(4):807-12. PubMed ID: 23910088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are Future Radiation Oncologists Equipped With the Knowledge to Manage Elderly Patients With Cancer?
    Morris L; Thiruthaneeswaran N; Lehman M; Hasselburg G; Turner S
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):743-747. PubMed ID: 28258899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Uro-oncology Society.
    Eskicorapci SY; Türkeri L; Karabulut E; Cal C; Akpinar H; Baltaci S; Baykal K; ; Kattan MW; Ozen H
    Urology; 2009 Dec; 74(6):1289-95. PubMed ID: 19589584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiparametric MRI for prostate cancer: a national survey of patterns of practice among radiation oncologists in Spain.
    Couñago F; Sancho G; Gómez-Iturriaga A; Henríquez I;
    Clin Transl Oncol; 2018 Nov; 20(11):1484-1491. PubMed ID: 29992463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.
    Nguyen CT; Kattan MW
    Cancer; 2009 Jul; 115(13 Suppl):3039-45. PubMed ID: 19544545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer risk estimation tool use by members of the American Urological Association: a survey based study.
    Otto BJ; Osterberg EC; Salgado S; Scherr DS; Shariat SF
    J Urol; 2015 Jun; 193(6):1933-7. PubMed ID: 25562444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy and surgery for high-risk localized prostate cancer: a UK questionnaire survey of urologists and clinical oncologists.
    Gnanapragasam VJ; Persad R; Payne HA
    BJU Int; 2012 Sep; 110(5):608-12. PubMed ID: 22765394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.